Results 131 to 140 of about 151,084 (348)

The reverse protraction factor in the induction of bone sarcomas in radium-224 patients [PDF]

, 1990
More than 50 bone sarcomas have occurred among a collective of about 800 patients who had been injected in Germany after World War II with large activities of radium-224 for the intended treatment of bone tuberculosis and ankylosing spondylitis.^In an ...
Chmelevsky, D., Kellerer, Albrecht M., Mays, C. W., Spiess, H.   +3 more
core   +1 more source

Progress in our understanding of the pathogenesis of ankylosing spondylitis

Rheumatology, 2018
AS is a common rheumatic condition characterized by inflammation and new bone formation. The pathogenesis of AS is likely multifactorial and has not been fully elucidated to date. A major genetic role has been demonstrated.
D. Simone, M Hussein Al Mossawi, P. Bowness   +2 more
semanticscholar   +1 more source

A review of the Infectious Diseases Society of America (IDSA) guidelines on the diagnosis and treatment of spondylitis in adults [PDF]

Клиническая микробиология и антимикробная химиотерапия, 2017
Spondylitis is a common disease in general clinical practice, which can be associated with a serious risk of adverse outcomes and severe disabling effects in case of late diagnosis and inadequate management of the patient.
Karpov I.A., Gorbich Yu.L., Solovey N.V., Raznitsyna O.T.   +3 more
doaj  

Ankylosing spondylitis risk factors: a systematic literature review

Clinical Rheumatology, 2021
M. Hwang, Lauren K Ridley, J. Reveille
semanticscholar   +1 more source

Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study

Arthritis Research & Therapy, 2016
BackgroundCT-P13 (Remsima®, Inflectra®) is a biosimilar of the infliximab reference product (RP; Remicade®) and is approved in Europe and elsewhere, mostly for the same indications as RP.
W. Park, D. Yoo, J. Jaworski, J. Brzezicki, A. Gnylorybov, V. Kadinov, I. G. Sariego, C. Abud-Mendoza, W. Escalante, S. Kang, D. Andersone, F. Blanco, SeungSuh Hong, S. H. Lee, J. Braun   +14 more
semanticscholar   +1 more source

Effects of psoriatic arthritis‐targeted drugs on bone remodeling: Clinical evidence and molecular pathways

Rheumatology &Autoimmunity, EarlyView.
Mechanisms and therapeutic targets in psoriatic arthritis: balancing inflammatory bone resorption and bone formation. Abstract Psoriatic arthritis (PsA) is a chronic inflammatory disease characterized by diverse clinical manifestations. Of particular concern, osteopenia and osteoporosis are prevalent in 45.27% and 12.94% of PsA patients, respectively ...
Yingchao Sun, Cheng Xu, Mingli Ouyang, Yongmei Han   +3 more
wiley   +1 more source

Emerging patterns of genetic overlap across autoimmune disorders. [PDF]

, 2012
Most of the recently identified autoimmunity loci are shared among multiple autoimmune diseases. The pattern of genetic association with autoimmune phenotypes varies, suggesting that certain subgroups of autoimmune diseases are likely to share ...
Criswell, Lindsey A, Richard-Miceli, Corinne   +1 more
core   +1 more source

Comparative Effectiveness and Safety of Adalimumab, Secukinumab, and Upadacitinib in Psoriatic Arthritis: A Prospective Cohort Study Based on PARWCH Cohort

The Journal of Dermatology, EarlyView.
ABSTRACT Psoriatic arthritis (PsA) is a chronic inflammatory disease, with prevalence among psoriasis patients ranging from 6% to 42% across populations. Although targeted therapies such as adalimumab (ADA), secukinumab (SEC), and upadacitinib (UPA) have demonstrated efficacy in randomized controlled trials, real‐world head‐to‐head comparisons remain ...
Yiyi Wang, Jingya Gao, Furong Li, Luyuan Li, Yue Xiao, Hongxiang Hu, Xiya Peng, Min Yang, Dan Hao, Wei Yan, Dengmei Xia, Wei Li   +11 more
wiley   +1 more source

B3GNT2, GPR35, PSMG1 Gene Polymorphisms Are Related With Susceptibility and Severity of Ankylosing Spondylitis in Chinese Han Population. [PDF]

Mol Genet Genomic Med
B3GNT2, GPR35, and PSMG1genes are related to ankylosing spondylitis in the Chinese Han population. ABSTRACT Background Latest research on ankylosing spondylitis (AS) indicates a link between the B3GNT2, PSMG1 genes and susceptibility to AS among western populations.
Lian Z, Zhao B, Luo W, Liu J, Wang J, Chai W, Wang Y, Ye S, Ma X.   +8 more
europepmc   +2 more sources

Characterization of Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis in the US‐Based Corrona Registry

Arthritis care & research, 2018
To describe the characteristics of patients with ankylosing spondylitis (AS) and patients with nonradiographic axial spondyloarthritis (SpA) in the US.
P. Mease, D. Heijde, C. Karki, J. Palmer, Mei Liu, R. Pandurengan, Yujin Park, J. Greenberg   +7 more
semanticscholar   +1 more source